Virtual Education for Youth with Type 1 Diabetes

CGM Academy for Youth With Type 1 Diabetes

Recruiting N/A Interventional Study
Type1 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 – 18
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
90 (estimated)
Sponsor
Children's Hospital Los Angeles · Other
Who this trial is looking for

This trial is looking for young people aged 8-18 who have type 1 diabetes. Participants will receive specialized online education about managing their diabetes and complete some questionnaires over time.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 8 and 18 years old.
  • I have been diagnosed with type 1 diabetes for at least 6 months.
  • I can speak, read, and write in English or Spanish.
  • I have a smartphone compatible with the Dexcom G6 and G7 app.
  • I can take part in virtual visits.

You may not be able to join if

  • I have a known history of medical adhesive allergies.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this randomized clinical trial is to compare the effects of a virtual education curriculum in blood glucose variation of youth with type 1 diabetes wearing continuous glucose monitoring (CGM) device. The main questions the study aims to answer are: * Do participants undertaking the proposed curriculum present improved glucose variation than participants of standard education? * Explor…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7 * T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D * Able to speak, read, and write English or Spanish * Smartphone compatible with Dexcom G6 an…
Contacts

Rebecca Barber, PhD, RN

(323) 361-1359

rbarber@chla.usc.edu

CONTACT

Natalia Garban

ngarban@chla.usc.edu

CONTACT